Literature DB >> 17041487

Successful treatment of a patient with refractory adult-onset still disease with anakinra.

Alla Rudinskaya, David H Trock.   

Abstract

Entities:  

Year:  2003        PMID： 17041487     DOI： 10.1097/01.rhu.0000089966.48691.7f

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  16 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 2.  Autoinflammation: translating mechanism to therapy.

Authors:  Taylor A Doherty; Susannah D Brydges; Hal M Hoffman
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

3.  May anakinra be used earlier in adult onset Still disease?

Authors:  Guillaume Moulis; Laurent Sailler; Leonardo Astudillo; Gregory Pugnet; Philippe Arlet
Journal:  Clin Rheumatol       Date:  2010-04-30       Impact factor: 2.980

4.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 5.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

6.  Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset Still's disease.

Authors:  Irene Sollano-Sancho; Beatriz Rubio-Cebrian; Maria Luisa de la Cruz; Blanca San-Jose-Montano
Journal:  Eur J Hosp Pharm       Date:  2020-08-11

Review 7.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 8.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

Review 9.  Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Authors:  Apostolos Kontzias; Petros Efthimiou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 10.  Progress in Biological Therapies for Adult-Onset Still's Disease.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Paolo Sfriso
Journal:  Biologics       Date:  2022-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.